Evidence-Based Benefits
- Mood support (meta-analysis) — a 2019 meta-analysis of 11 RCTs in the Journal of Integrative Medicine found saffron supplementation significantly reduced depression scores compared to placebo. This meta-analysis result does not establish saffron as a clinical replacement for prescribed antidepressants, and saffron should not be combined with SSRIs, SNRIs, or MAOIs without prescriber guidance because of serotonin-syndrome risk
- Head-to-head trial findings — multiple RCTs have compared 30mg saffron extract to fluoxetine (20mg) and citalopram (20mg) in mild-to-moderate depressive symptoms; trial groups showed similar improvement on depression scales, with fewer reported sexual side effects in the saffron arms. Caveat: these single-trial findings do not establish saffron as a clinical substitute for SSRIs, and combining saffron with SSRIs, SNRIs, or MAOIs carries a serotonin-syndrome risk — never use both without prescriber guidance
- Sleep quality — a 2020 RCT found 28mg affron saffron extract improved sleep quality scores by 36% in adults with self-reported sleep complaints, likely through GABAergic and serotonergic mechanisms
- Anxiety reduction — saffron's effect on GABA and serotonin pathways provides mild anxiolytic activity alongside its antidepressant effects, making it useful for the common overlap of anxiety and low mood
- PMS and emotional wellbeing — a 2008 RCT in the British Journal of Obstetrics and Gynaecology found saffron significantly reduced PMS symptoms including mood changes, irritability, and discomfort